XML 168 R36.htm IDEA: XBRL DOCUMENT v3.25.0.1
Debt - (Tables)
12 Months Ended
Dec. 31, 2024
Debt Instrument, Redemption [Line Items]  
Summary of liability for sale of future royalties

The following table shows the activity within the “liability for sale of future royalties- current” and “liability for sale of future royalties- noncurrent” accounts for the year ended December 31, 2024:

    

Year Ended December 31, 

Liability for sale of future royalties- (current and noncurrent)

2024

Beginning balance as of December 31, 2023

$

1,814,097

Less: Non-cash royalty revenue payable to Royalty Pharma

(181,507)

Plus: Non-cash interest expense recognized

207,394

Plus: Cash received from Royalty Pharma

241,792

Ending balance

$

2,081,776

Effective interest rate as of December 31, 2024

 

9.8%

1.50% Convertible senior notes due 2026  
Debt Instrument, Redemption [Line Items]  
Summary of convertible notes

The 2026 Convertible Notes consist of the following:

Year ended 
December 31,

2024

2023

Principal

$

287,500

$

287,500

Less: Debt issuance costs

 

(2,088)

(3,287)

Net carrying amount

$

285,412

$

284,213

Summary of interest expense recognized related to debt

The following table sets forth total interest expense recognized related to the 2026 Convertible Notes:

December 31,

    

2024

2023

Contractual interest expense

$

4,319

$

4,305

Amortization of debt issuance costs

 

1,198

1,171

Total

$

5,517

$

5,476

Effective interest rate

 

1.9

%

1.9

%

Blackstone Credit Agreement  
Debt Instrument, Redemption [Line Items]  
Schedule of credit agreement

The Blackstone Credit Agreement consisted of the following:

    

December 31, 2024

December 31, 2023

Principal

$

$

300,000

Less: Debt issuance costs

 

Repayment of senior secured term loan

(300,000)

Net carrying amount

$

$

Summary of interest expense recognized related to debt

The following table sets forth total interest expense recognized related to the Blackstone Credit Agreement:

Year Ended

Year Ended

December 31, 

December 31, 

2024

2023

Contractual interest expense

$

$

30,198

Amortization of debt issuance costs

702

Total

$

$

30,900

Effective interest rate

%

13.1

%